Studies in mouse models of multiple sclerosis have found that CBD (10 mg/kg, i.p.)can affect the levels of both H3K4me3 and H3K27me3 at specific genes, such as IL-4, IL-5, and IL-13, in splenic CD4+ T cells [58]. The gene discussed is CD4; the disease is multiple sclerosis.